Insulet Corp (PODD)
261.16
-7.90
(-2.94%)
USD |
NASDAQ |
Nov 14, 16:00
261.04
-0.12
(-0.05%)
After-Hours: 20:00
Insulet Gross Profit (Annual): 1.160B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.160B |
| December 31, 2022 | 805.60M |
| December 31, 2021 | 752.10M |
| December 31, 2020 | 582.30M |
| December 31, 2019 | 480.30M |
| December 31, 2018 | 370.20M |
| December 31, 2017 | 277.20M |
| December 31, 2016 | 211.09M |
| December 31, 2015 | 133.27M |
| December 31, 2014 | 127.13M |
| December 31, 2013 | 112.40M |
| Date | Value |
|---|---|
| December 31, 2012 | 92.34M |
| December 31, 2011 | 66.71M |
| December 31, 2010 | 43.73M |
| December 31, 2009 | 18.30M |
| December 31, 2008 | -4.584M |
| December 31, 2007 | -12.36M |
| December 31, 2006 | -12.00M |
| December 31, 2005 | -1.48M |
| December 31, 2004 | |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
480.30M
Minimum
2019
1.160B
Maximum
2023
756.04M
Average
752.10M
Median
2021
Gross Profit (Annual) Benchmarks
| Baxter International Inc | 4.975B |
| Boston Scientific Corp | 9.895B |
| Abbott Laboratories | 22.13B |
| Globus Medical Inc | 1.020B |
| Bioventus Inc | 328.19M |